JLPC: Benzenesulfonic Acid Amlodipine Tablets Complete Drug Registration
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, JLPC announced that its holding subsidiary, Xinxiang Changle Pharmaceutical Co., Ltd. (referred to as "Changle Pharmaceutical"), recently received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration, for the drug named Amlodipine Besylate Tablets. Amlodipine Besylate Tablets are a commonly used medication for regulating vascular pressure
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments